1735 related articles for article (PubMed ID: 23161624)
1. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of somatostatin and cortistatin receptors.
Siehler S; Nunn C; Hannon J; Feuerbach D; Hoyer D
Mol Cell Endocrinol; 2008 May; 286(1-2):26-34. PubMed ID: 18243519
[TBL] [Abstract][Full Text] [Related]
3. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
Dumont Y; Chabot JG; Quirion R
Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
[TBL] [Abstract][Full Text] [Related]
4. Agonist ligand discrimination by the two orexin receptors depends on the expression system.
Putula J; Turunen PM; Jäntti MH; Ekholm ME; Kukkonen JP
Neurosci Lett; 2011 Apr; 494(1):57-60. PubMed ID: 21362456
[TBL] [Abstract][Full Text] [Related]
5. Orphan G protein-coupled receptors and obesity.
Xu YL; Jackson VR; Civelli O
Eur J Pharmacol; 2004 Oct; 500(1-3):243-53. PubMed ID: 15464037
[TBL] [Abstract][Full Text] [Related]
6. Orexin and central regulation of cardiorespiratory system.
Shahid IZ; Rahman AA; Pilowsky PM
Vitam Horm; 2012; 89():159-84. PubMed ID: 22640613
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptides: opportunities for drug discovery.
Hökfelt T; Bartfai T; Bloom F
Lancet Neurol; 2003 Aug; 2(8):463-72. PubMed ID: 12878434
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders.
Holmes A; Heilig M; Rupniak NM; Steckler T; Griebel G
Trends Pharmacol Sci; 2003 Nov; 24(11):580-8. PubMed ID: 14607081
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin, cortistatin, ghrelin and glucose metabolism.
Gauna C; van der Lely AJ
J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
[TBL] [Abstract][Full Text] [Related]
10. The role of orexin/hypocretin in the central nervous system and peripheral tissues.
Tsunematsu T; Yamanaka A
Vitam Horm; 2012; 89():19-33. PubMed ID: 22640606
[TBL] [Abstract][Full Text] [Related]
11. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.
Xu TR; Yang Y; Ward R; Gao L; Liu Y
Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208
[TBL] [Abstract][Full Text] [Related]
12. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology.
Sakurai T
Regul Pept; 2005 Mar; 126(1-2):3-10. PubMed ID: 15620407
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin, cortistatin and their receptors in tumours.
Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
[TBL] [Abstract][Full Text] [Related]
14. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.
Guerrini R; Salvadori S; Rizzi A; Regoli D; Calo' G
Med Res Rev; 2010 Sep; 30(5):751-77. PubMed ID: 19824051
[TBL] [Abstract][Full Text] [Related]
15. Deorphanisation of G protein-coupled receptors: A tool to provide new insights in nervous system pathophysiology and new targets for psycho-active drugs.
Lecca D; Abbracchio MP
Neurochem Int; 2008 Feb; 52(3):339-51. PubMed ID: 17884255
[TBL] [Abstract][Full Text] [Related]
16. [Receptors for oreksins: structure, localisation and activation mechanisms].
Abramova TV; Perekrest SV; Shainidze KZ; Novikova NS; Korneva EA
Ross Fiziol Zh Im I M Sechenova; 2011 Sep; 97(9):995-1007. PubMed ID: 22165210
[TBL] [Abstract][Full Text] [Related]
17. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
Ohno K; Sakurai T
Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
[TBL] [Abstract][Full Text] [Related]
18. Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.
Bonifazi A; Del Bello F; Giorgioni G; Piergentili A; Saab E; Botticelli L; Cifani C; Micioni Di Bonaventura E; Micioni Di Bonaventura MV; Quaglia W
Med Res Rev; 2023 Sep; 43(5):1607-1667. PubMed ID: 37036052
[TBL] [Abstract][Full Text] [Related]
19. Mini-review: the evolution of neuropeptide signaling.
Grimmelikhuijzen CJ; Hauser F
Regul Pept; 2012 Aug; 177 Suppl():S6-9. PubMed ID: 22726357
[TBL] [Abstract][Full Text] [Related]
20. Autocrine and paracrine signaling through neuropeptide receptors in human cancer.
Heasley LE
Oncogene; 2001 Mar; 20(13):1563-9. PubMed ID: 11313903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
